SREBF2 and breast cancer: K-Ras activates the mTORC1/SREBPs (SREBP1 and SREBP2) signaling pathway and enhances the autonomous growth of breast cancer cells by activating Erk with minimal activation of Akt (Ricoult et al., 2016).